This inventor holds 3 USPTO granted patents. Top assignee: Millennium Health, LLC. Active years: 2018-2023.
Company Filing History:
Years Active: 2018-2023
Title: Kulvi Kaur: Innovator in Genetic Biomarkers
Introduction
Kulvi Kaur is a notable inventor based in Encinitas, California. He has made significant contributions to the field of genetics, particularly in the identification of biomarkers for drug reactions. With a total of three patents to his name, Kaur's work is paving the way for advancements in personalized medicine.
Latest Patents
Kaur's latest patents focus on a novel single nucleotide polymorphism (SNP) in HLA-B*15:02. This SNP can be utilized as a biomarker for predicting severe adverse skin reactions induced by carbamazepine, especially in Asian populations. The patents also detail methods and reagents for assessing this specific SNP, which can help in predicting an increased risk of these severe reactions.
Career Highlights
Kaur is currently employed at Millennium Health, LLC, where he continues to innovate in the field of genetic research. His work is crucial in enhancing the safety and efficacy of medications through genetic testing.
Collaborations
Kaur collaborates with esteemed colleagues such as Hua Fang and Xiequn Xu, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Kulvi Kaur's contributions to genetic biomarkers are significant and impactful. His work not only advances scientific understanding but also enhances patient safety in medication use.